Stough Group to spend $3,068,000.00 to expand into new space in Chicago Illinois.
Chicago, Illinois — According to state and local economic development sources Stough Group plans to invest $3,068,000.00 to build out new space in Chicago. The company plans to occupy the new space at 2722 N Central Ave in Chicago, on or about June 1, 2023. According to the company website Plasma therapies were developed during the 2nd World War to treat battlefield casualties. But during peace time, there was no reliable source of human plasma to manufacture life-saving drugs. In the late ’60s, Dr. Austin R. Stough formed Stough Enterprises, Inc. (SEI), and began developing off-street plasma donor facilities to meet this demand. Contracts were formed early on with Hyland Laboratories of Oak Park, IL, and Cutter Laboratories of Berkeley, CA. Stough Enterprises expanded rapidly, and at Dr. Stough’s death in 1972, was a recognized leader in the operation of commercial plasmapheresis centers. As Stough Group passes a half century in business, the founder’s grandson takes the reins as CEO. Scott is enhancing our proven approach with his unique leadership and site selection skills. As Chairman, Michael is still on the job, laser-beam focused on making collection facilities more attractive, comfortable, clean, efficient and safe. Our goal is to raise the best industry standards even higher, delivering the ultimate facilities for long-term client success.
To learn more about Stough Group, visit http://www.stoughgroup.com/
Company Contact:
Scott Stough, Chief Executive Officer
sstough@stoughgroup.com
https://www.linkedin.com/in/scott-stough-66a59923/
513-842-0240
SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved